双特异性抗体在扩散性大B细胞淋巴瘤中的演变作用
Khalil Saleh1, Rita Khoury1, Nadine Khalife2
1International Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
双特异性抗体 (BsAbs) 正在彻底改变扩散型大B细胞淋巴瘤 (DLBCL) 治疗. 本综述探讨了它们的结构,有效性和抵抗机制,强调了它们在管理DLBCL中的日益增长的作用.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 向疗法,包括单克隆抗体,CAR-T细胞和抗体-药物联合体 (ADC),已经改变了扩散性大B细胞淋巴瘤 (DLBCL) 治疗.
- 利图西马布,CAR T细胞和波拉图祖马布 (一种ADC) 是DLBCL的已知疗法.
- 双特异性抗体 (BsAbs) 是一种新型药物类别,在DLBCL治疗中具有显著的潜力.
研究的目的:
- 审查双特异抗体 (BsAbs) 的结构和作用机制.
- 分析BsAbs在治疗扩散性大B细胞淋巴瘤 (DLBCL) 的临床疗效.
- 讨论DLBCL中对BsAbs的抵抗机制.
主要方法:
- 对DLBCL双特异抗体的临床试验和研究研究的文献综述.
- 对已批准的BsAbs (glofitamab,epcoritamab) 和正在进行的组合策略进行分析.
- 探索 BsAbs. 的结构组件和约束特征.
主要成果:
- 两种BsAbs,glofitamab和epcoritamab,已被批准用于第三线DLBCL治疗.
- 涉及BsAbs与化疗,免疫疗法和ADCs的组合策略显示出有希望的结果.
- 目前正在进行的研究重点是优化BsAb在一线和后续治疗环境中的使用.
结论:
- 双特异性抗体 (BsAbs) 正在成为扩散性大B细胞淋巴瘤 (DLBCL) 的关键治疗方式.
- 了解BsAb机制,疗效和耐药性对于推进DLBCL治疗模式至关重要.
- 未来的研究方向包括新的组合疗法和克服耐药性的策略.
更多相关视频
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
相关概念视频
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Immunotherapy
